HBIO · Harvard Bioscience Inc
$6.66
-0.02 (-0.22%)
At close · Aug 14
Market Cap
$30.30M
Shares
4.55M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John Duke | President & Chief Executive Officer | $905,208 |
| James Green | — | $355,823 |
| Mark Frost | Chief Financial Officer & Treasurer | $343,518 |
| Jennifer Cote | Former Chief Financial Officer and Treasurer | $123,006 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Former Chairman | President & Chief Executive Officer | $2,336,576 |
| James Green | Chairman, President & Chief Executive Officer | $2,336,576 |
| Jennifer Cote | Chief Financial Officer and Treasurer | $602,601 |
| Mark Frost | Chief Financial Officer & Treasurer | — |
| John Duke | President & Chief Executive Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| James Green | Chairman, President & Chief Executive Officer | $2,392,240 |
| Jennifer Cote | Chief Financial Officer and Treasurer | $571,272 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| James Green | Chairman, President & Chief Executive Officer | $2,328,470 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James Green | President and Chief Executive Officer | $2,737,454 |
| Michael Rossi | Chief Financial Officer | $818,750 |
| Kenneth Olson | Chief Operating Officer | $704,311 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| James Green | President and Chief Executive Officer | $2,620,453 |
| Kenneth Olson | Chief Operating Officer | $829,082 |
| Michael Rossi | Chief Financial Officer | $778,161 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| James Green | President and Chief Executive Officer | $2,280,723 |
| Michael Rossi | Chief Financial Officer | $320,547 |
| Kenneth Olson | Chief Operating Officer | $156,321 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Katherine A. Eade | Class II Director | Appointed | 2026-06-02 |
| John Duke | Class II Director | Appointed | 2026-06-02 |
| Mark Frost | Chief Financial Officer and Treasurer | Appointed | 2026-03-10 |
| Stephen DeNelsky | member of the Board | Appointed | 2025-09-09 |
| Seth Benson | members of the Board | Appointed | 2025-07-17 |
| John Duke | President and Chief Executive Officer | Appointed | 2025-07-17 |
| Robert Gagnon | members of the Board | Appointed | 2025-07-17 |
| James W. Green | Chairman of the Board | Resigned | 2025-07-17 |
| James W. Green | member of the Board | Resigned | 2025-07-17 |
| James W. Green | President and Chief Executive Officer | Resigned | 2025-07-17 |
| Alan Edrick | board of directors | Resigned | 2025-06-13 |
| Katherine Eade | Lead Independent Director | Appointed | 2025-06-02 |
| John D. Duke | member of the Board | Appointed | 2025-06-02 |
| Thomas Loewald | board of directors | Resigned | 2025-06-02 |
| Jennifer Cote | Chief Financial Officer and Treasurer | Appointed | 2023-06-20 |
| Michael Rossi | Chief Financial Officer and Treasurer | Resigned | 2023-01-19 |
| Michael Rossi | Chief Financial Officer and Treasurer | Resigned | 2022-12-12 |
| Bertrand Loy | Class I Director | Appointed | 2022-05-17 |
| James W. Green | Class I Director | Appointed | 2022-05-17 |
Key facts
CIK
1123494
CUSIP
416906204
13F (30d)
42 filings
35 filers
Visit website
Investor relations